Andrew Eriksen
Allele Capital Partners, LLC

I think we're live right now. So let's jump in. Thank you, everyone, for joining today -- into today's webinar, inside the PetVivo story. What veterinarians are seeing, and how access is expanding. So my name is Andrew Eriksen. I'm a Managing Director on the Allele Capital team. We work with the PetVivo team here, and I'll be moderating today's call. So today, we're going to introduce the speakers. I'll walk through a little bit of background on the PetVivo story, talk about how their Spryng technology is being used in practice today and talk a little bit about the commercial landscape, and what they're seeing on their side.

So we will run through the presentation. If you have any questions, there will be a Q&A chat box on either platform that you're watching on. So submit your questions there, and we'll make sure we get to those at the end of the call.

So without further ado, let's jump in. I will start with some brief introductions from the team. So John, maybe you can kick things off for us and introduce yourself.

John Lai
CEO, President & Director

Thanks for having us on here. So my name is John Lai. I'm the CEO of PetVivo. I've been the CEO for about 14 years, and I'll pass it off to the next person.

Andrew Eriksen
Allele Capital Partners, LLC

Dr. Juli, if you don't mind, you can go next.